Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–9 of 9 results
Advanced filters: Author: Ifeoma Ulasi Clear advanced filters
  • The theme of World Kidney Day 2024 is “kidney health for all — advancing equitable access to care and optimal medication practice”. To mark this event, Nature Reviews Nephrology invited five researchers from different geographical regions worldwide to discuss the impact of new and emerging therapies for diabetic kidney disease on patient care as well as the barriers that must be overcome to ensure equitable access to these therapies.

    • Ricardo Correa-Rotter
    • Louise J. Maple-Brown
    • Ifeoma I. Ulasi
    Reviews
    Nature Reviews Nephrology
    Volume: 20, P: 156-160
  • Africa has a high prevalence of chronic kidney disease (CKD), but efforts to address this burden lag behind those of high-income regions. In the past 20 years, progress has been made in collaborative efforts to share clinical and diagnostic skills and better define the epidemiology and pathophysiology of CKD in Africa.

    • Ifeoma I. Ulasi
    • Ugochi C. Onu
    Comments & Opinion
    Nature Reviews Nephrology
    Volume: 21, P: 720-721
  • Addressing the burden of non-communicable diseases is a global public health priority. In this joint Consensus Statement, the American Society of Nephrology, the European Renal Association and the International Society of Nephrology highlight the need to recognize kidney disease as a key driver of premature mortality, in addition to other non-communicable diseases already prioritized by the World Health Organization.

    • Anna Francis
    • Meera N. Harhay
    • Vivekanand Jha
    Reviews
    Nature Reviews Nephrology
    Volume: 20, P: 473-485
  • Unpleasant symptoms — arising as a consequence of disease processes, comorbid conditions, therapeutics and lifestyle regimens — adversely affect the quality of life and life participation of patients with chronic kidney disease (CKD). This Perspective examines the concept and scope of symptom burden in CKD, theoretical frameworks and validated tools for symptom appraisal, and strategies with which to support patients actively through the identification and targeting of unpleasant symptoms.

    • Kamyar Kalantar-Zadeh
    • Mark B. Lockwood
    • Philip Kam-Tao Li
    Reviews
    Nature Reviews Nephrology
    Volume: 18, P: 185-198
  • Working towards sustainable development is essential to tackle the rise in the global burden of non-communicable diseases, including kidney disease. Five years after the Sustainable Development Goal agenda was set, this Review examines the progress thus far, highlighting future challenges and opportunities, and explores the implications for kidney disease.

    • Valerie A. Luyckx
    • Ziyad Al-Aly
    • John Stanifer
    Reviews
    Nature Reviews Nephrology
    Volume: 17, P: 15-32
  • To leverage the genetic diversity in Nigeria, we established the Non-Communicable Diseases Genetic Heritage Study (NCD-GHS) consortium to help produce a comprehensive catalog of human genetic variation in Nigeria and assess the burden and etiological characteristics of non-communicable diseases in 100,000 adults in Nigeria.

    • Segun Fatumo
    • Aminu Yakubu
    • Abasi Ene-Obong
    Comments & Opinion
    Nature Genetics
    Volume: 54, P: 531-536